In recent years, Novogene Europe has systematically integrated state-of-the-art technologies across its service portfolio, ...

Dr Lal PathLabs has expanded its genomics capabilities by adding Illumina’s NovaSeq X Series to its dedicated genomics division, Genevolve. With the integration of Illumina’s latest technology, DLPL ...

Illumina, Inc. (NASDAQ: ILMN) announced it has entered into a definitive agreement with Standard BioTools (NASDAQ: LAB) under which Illumina will acquire SomaLogic, a leader in data-driven ...

Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round.

This transaction builds on a co-development agreement Illumina established with SomaLogic in December 2021 to bring the SomaScan® Proteomics Assay onto Illumina's high-throughput ...

Combines highly complementary proteomics expertise with Illumina's industry-leading product innovation and global market reach ...

This transaction builds on a co-development agreement Illumina established with SomaLogic in December 2021 to bring the SomaScan® Proteomics Assay onto Illumina's high-throughput ...

In 2007, the next-generation sequencing technologies have come into their own with an impressive array of successful applications. Kelly Rae Chi reports.

Standard BioTools (NASDAQ: LAB) shares jumped as much as 19% premarket on Monday after the company announced the sale of its SomaLogic business to Illumina (NASDAQ: ILMN) for an aggregate cash ...

Uzbekistan has made significant progress in its transition to a market economy since 2017, achieving advancements in macroeconomic stabilization, trade and exchange rate liberalization, price ...